TY  - JOUR
AU  - Poveda, A.
AU  - Martinez, V.
AU  - Serrano, C.
AU  - Sevilla, I.
AU  - Lecumberri, M. J.
AU  - de Beveridge, R. D.
AU  - Estival, A.
AU  - Vicente, D.
AU  - Rubio, J.
AU  - Martin-Broto, J.
PY  - 2016
DO  - 10.1007/s12094-016-1579-9
SN  - 1699-048X
UR  - http://hdl.handle.net/10668/18651
T2  - Clinical & translational oncology
AB  - Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the digestive tract, and this disease has served as a paradigmatic model for successful rational development of targeted therapies. The introduction of tyrosine...
LA  - en
PB  - Springer-verlag italia srl
KW  - GIST
KW  - Imatinib
KW  - Sunitinib
KW  - Regorafenib
KW  - Stromal tumors
KW  - Adjuvant imatinib
KW  - Randomized-trial
KW  - Phase-iii
KW  - Follow-up
KW  - Kinase
KW  - Risk
KW  - Multicenter
KW  - Sensitivity
KW  - Recurrence
KW  - Gastrointestinal Neoplasms
KW  - Gastrointestinal Stromal Tumors
KW  - Humans
KW  - Practice Guidelines as Topic
KW  - Spain
TI  - SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016)
TY  - research article
VL  - 18
ER  -